CATX

Perspective Therapeutics Inc.

Price

$2.76

return (12m)

-24.18%

p/e

-2.81

p/bv

1.01

DIVIDEND YIELD

0.00%

CATX price

Perspective Therapeutics Inc.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CATX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-11.82%

3 months

-20.35%

1 year

-24.18%

2 years

-79.33%

5 years

-53.22%

10 years

-61.13%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CATX

Valuation

P/E

-2.81

Sector 7.51

Industry 7.51

P/BV

1.01

Sector 1.74

Industry 1.74

P/Revenue (PSR)

800.90

Sector 1.69

Industry 1.69

EV/EBITDA

-3.58

Sector -845.43

Industry -845.43

EV/EBIT

-3.43

Sector -3,320.87

Industry -3,320.87

P/EBITDA

-2.90

Sector -11.07

Industry -11.07

P/EBIT

-2.80

Sector -9.99

Industry -9.99

P/Total Assets

0.84

Sector 0.83

Industry 0.83

P/Net Current Assets

1.89

Sector -1.86

Industry -1.86

P/Working Capital

1.60

Sector -4,700.45

Industry -4,700.45

EPS

-0.97

Sector 0.72

Industry 0.72

BVPS

2.68

Sector 9.78

Industry 9.78

Efficiency

Gross Margin

100.00%

Sector 35.82%

Industry 35.82%

EBITDA Margin

-31,816.05%

Sector -200.09%

Industry -200.09%

EBIT Margin

-33,224.69%

Sector -130.42%

Industry -130.42%

Operating Margin

-100.00%

Sector 4.48%

Industry 4.48%

Net Profit Margins

-100.00%

Sector 2.53%

Industry 2.53%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-35.95%

Sector 2.55%

Industry 2.55%

ROA

-29.70%

Sector -0.60%

Industry -0.60%

ROIC

-78.53%

Sector -120.08%

Industry -120.08%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

Sector 9.87%

Industry 9.87%

Debt

Current Ratio

6.61

Sector 1.47

Industry 1.47

Net Debt / EBITDA

9.13

Sector -20.47

Industry -20.47

Net Debt / EBIT

8.74

Sector -164,248,318.64

Industry -164,248,318.64

Net Debt / Equity

-0.73

Sector -0.77

Industry -0.77

Gross Debt / Equity

0.00

Sector 0.20

Industry 0.20

Equity/Assets

0.83

Sector 0.43

Industry 0.43

Liabilities/Assets

0.17

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

-47.93%

Sector -

Industry -

5Y Earnings CAGR

83.13%

Sector -

Industry -

Fundamentals CATX

DRAG THE FRAME TO SEE MORE DATA

CATX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Perspective Therapeutics Inc.

Perspective Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

- year

Founded:

2005

Time since IPO - 21 years

163

Employees

Perspective Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $327.57 million, with shareholders equity totaling $323.86 million.

The company employs approximately 163 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Perspective Therapeutics Inc. reported $409.00 Thousand in revenue, generating net income of $-116.43 million.

Key financial metrics include a P/E ratio of -2.81, a price-to-book (P/B) ratio of 1.01, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CATX.

Market cap

$327.57 million

Net worth

$323.86 million

$323,863,000.00

Assets

$392.03 million

$392,025,000.00

Total Shares Outstanding

120.65 million

120,651,000

Average Daily Trading Volume

$1.58 million

$1,584,081.94

Sector

Others

Industry

Others

CATX

CATX revenue and profits

Financial Results CATX

DRAG THE FRAME TO SEE MORE DATA

CATX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$371.90 5,99% (12M)

P/E

23.51

2.46%

ROE

13.51%

P/BV

3.18

SHEL - Shell PLC ADR

$96.23 36,34% (12M)

P/E

10.30

3.16%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.40 --58,99% (12M)

P/E

-0.50

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$309.05 2,85% (12M)

P/E

22.61

0.78%

ROE

81.03%

P/BV

18.32

ALIZY - Allianz SE ADR

$46.83 --19,17% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$84.46 50,46% (12M)

P/E

6.86

4.78%

ROE

21.42%

P/BV

1.47

NSRGY - Nestle SA ADR

$90.24 1,04% (12M)

P/E

10.81

4.45%

ROE

58.05%

P/BV

6.27

ELV - Elevance Health Inc

$386.43 12,43% (12M)

P/E

19.87

1.71%

ROE

9.84%

P/BV

1.96